AR and prostate cancer: In vitro, androgen receptor negative and -inhibited prostate cancer cell lines were shown to increase prothrombin expression and thereby induce platelet aggregation and hypercoagulability as opposed to androgen receptor-positive prostate cancer cell lines [65].